Valuation: 22nd Century Group, Inc.

Capitalization 2.07M 1.78M 1.61M 1.54M 2.81M 190M 2.94M 19.01M 7.62M 91.06M 7.75M 7.59M 326M P/E ratio 2025 *
-0.45x
P/E ratio 2026 * -4.5x
Enterprise value 2.07M 1.78M 1.61M 1.54M 2.81M 190M 2.94M 19.01M 7.62M 91.06M 7.75M 7.59M 326M EV / Sales 2025 *
0.11x
EV / Sales 2026 * 0.06x
Free-Float
85.66%
Yield 2025 *
-
Yield 2026 * -
1 day+2.27%
1 week-11.38%
Current month-11.38%
1 month-30.29%
3 months-74.53%
6 months-84.21%
Current year-64.94%
1 week 3.61
Extreme 3.61
4.63
1 month 3.61
Extreme 3.61
6.86
Current year 3.61
Extreme 3.61
14.85
1 year 3.61
Extreme 3.61
841.8
3 years 3.61
Extreme 3.61
1,000,000
5 years 3.61
Extreme 3.61
1,000,000
10 years 3.61
Extreme 3.61
1,000,000
Manager TitleAgeSince
Chief Executive Officer 68 2023-11-27
Director of Finance/CFO 36 2024-04-05
Chief Operating Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 79 2022-09-11
Director/Board Member 66 2023-07-18
Chairman 68 2023-11-27
Change 5d. change 1-year change 3-years change Capi.($)
+2.27%-11.38%-99.43%-100.00% 2.07M
-0.70%-3.66%+16.66%+40.94% 111B
+0.60%-4.56%+48.11%+107.14% 64.36B
-0.58%-1.24%-23.66%-20.21% 42.22B
-1.21%-5.15%+55.95%+77.82% 10.81B
-2.96%-9.39%+49.09%-29.91% 5.63B
-0.44%-7.02%-3.85%-8.54% 2.74B
+1.32%-6.46%+22.72%+193.14% 2.29B
-1.29%-11.85%+44.21%-42.67% 1.73B
-0.55%-3.70%+12.35%+17.42% 1.17B
Average -0.35%-6.62%+12.21%+23.51% 24.22B
Weighted average by Cap. -0.39%-3.66%+20.50%+48.04%

Financials

2025 *2026 *
Net sales 18.1M 15.61M 14.09M 13.52M 24.65M 1.66B 25.8M 167M 66.72M 798M 67.93M 66.48M 2.85B 32.5M 28.02M 25.3M 24.27M 44.26M 2.99B 46.32M 299M 120M 1.43B 122M 119M 5.12B
Net income -5.7M -4.91M -4.44M -4.26M -7.76M -524M -8.12M -52.45M -21.01M -251M -21.39M -20.94M -898M -1.34M -1.16M -1.04M -1M -1.82M -123M -1.91M -12.33M -4.94M -59.06M -5.03M -4.92M -211M
Net Debt - -
Logo 22nd Century Group, Inc.
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.
Employees
56
Sector
Tobacco
Date Price Change Volume
26-03-06 4.050 $ +2.27% 17,169
26-03-05 3.960 $ -0.75% 22,902
26-03-04 3.990 $ +0.50% 31,943
26-03-03 3.970 $ -8.74% 177,564
26-03-02 4.350 $ -4.81% 21,547

Quarterly revenue - Rate of surprise